1999
DOI: 10.1016/s0890-6238(99)00013-1
|View full text |Cite
|
Sign up to set email alerts
|

Developmental toxicity in rat fetuses exposed to the benzimidazole netobimin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
0
2

Year Published

2004
2004
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 26 publications
1
15
0
2
Order By: Relevance
“…Since, they inhibit cell growth and differentiation of micromass culture of rat embryo midbrain and limb bud cells. In agreement with our result, Capece et al [39], Navarro et al [40] reported that benzimidazole induces a significant increase of resorptions, a decrease of fetal body weights and an increase in skeletal malformation. Mantovni [41] and Teruel et al [42] indicated that the benzimidazole anthelmintic, albendazole, shows a dose related increase in embryolethality, growth reduction and a reduction in the ossification process in the rat.…”
Section: Discussionsupporting
confidence: 94%
“…Since, they inhibit cell growth and differentiation of micromass culture of rat embryo midbrain and limb bud cells. In agreement with our result, Capece et al [39], Navarro et al [40] reported that benzimidazole induces a significant increase of resorptions, a decrease of fetal body weights and an increase in skeletal malformation. Mantovni [41] and Teruel et al [42] indicated that the benzimidazole anthelmintic, albendazole, shows a dose related increase in embryolethality, growth reduction and a reduction in the ossification process in the rat.…”
Section: Discussionsupporting
confidence: 94%
“…El ABZ y el SOABZ han sido usados como modelos para elucidar la inducción de dismorfogénesis provocadas por los benzimidazoles, habiendo sido demostrado en ovinos (Marriner, 1986;Fabre et al, 1989;McKellar & Scott, 1990), vacunos (Delatour et al, 1981;Piscopo & Smoak, 1997) y ratas (Mantovani et al, 1995;Cristófol et al,1997;Piscopo & Smoak;Navarro et al, 1999;Teruel et al, 2003). La actividad teratógena del ABZ in vivo es atribuida al SOABZ, debido a su mayor concentración sistémica cuando es comparada a la del ABZ (Delatour et al, 1984).…”
Section: Introductionunclassified
“…3,4 Further ABZ-SO is oxidized to ABZ sulphone (ABZ-SO 2 ), 3,5 in a process catalyzed by cytochrome P450 and, finally, to ABZ 2-aminosulphone (ABZ-SO 2 NH 2 ), the N-deacetylation product of ABZ sulphone. 6 Of all three metabolites, pharmacokinetics studies indicate that ABZ-SO exhibit anthelmintic activity 7 and toxic effects, 8 whereas ABZ-SO 2 and ABZ-SO 2 NH 2 are considered biologically inactive. 8,9 Chemical structures of ABZ and its metabolites are displayed in Scheme 1.…”
Section: Introductionmentioning
confidence: 99%